Episodes

  • Talking the Cure - Exploring the industry with Alice Valder Curran

    Talking the Cure - Exploring the industry with Alice Valder Curran
    Nov 16 2023
    In this episode, Alice Valder Curran sits down with us to talk about her impressive career, why she ultimately chose Hogan Lovells as her employer, and what it takes to be successful in this area of the industry, even in times when you can only work part-time. Alice gives us a behind-the-scenes look at how to create your own niche and surround yourself with people who have the same standards for themselves and the same sense of quality.
    Show more Show less
    39 mins
  • Talking the Cure - Exploring the industry with Randy Prebula

    Talking the Cure - Exploring the industry with Randy Prebula
    Oct 23 2023
    In this episode, Randy Prebular sits down with us and we talk about his impressive professional career, how he actually wanted to be a pediatrician at the beginning of his career, and how he then went from being a research scientist to a partner in a major law firm. We hear many exciting anecdotes, Randy gives us a behind-the-scenes look and tips on how young lawyers can make their careers more successful.
    Show more Show less
    46 mins
  • Talking the Cure - Discussing the implications of the Inflation Reduction Act (IRA)

    Talking the Cure - Discussing the implications of the Inflation Reduction Act (IRA)
    Sep 28 2023
    In this podcast episode, Alice Curran and Cullen Taylor discuss the implications of the Inflation Reduction Act (IRA) on the life sciences and healthcare sector. They explore how IRA can impact drug pricing, development, collaboration, and partnerships. The episode covers assessing IRA’s impact, economic provisions in agreements, launch strategies, backup compounds, fixed-dose combinations, and the challenges of out-licensing. They highlight the complexities and potential risks in dealing with IRA.
    Show more Show less
    31 mins
  • Talking the Cure - Discussing latest developments​ іn clinical trials diversity, driven​ by FDORA

    Talking the Cure - Discussing latest developments​ іn clinical trials diversity, driven​ by FDORA
    Sep 6 2023
    In this episode​ оf 'Talking the Cure,'​ we dive into the latest developments​ іn clinical trials diversity, driven​ by the Food and Drug Omnibus Reform Act (FDORA). Join Stephanie Agu, Akosua Tuffuor and Deborah Cho​ as​ we explore FDORA's key provisions related to diversity action plans. We'll briefly summarize the history​ оf FDA's efforts​ іn this area, discuss the impact​ оf FDORA, examine the challenges and unknowns​ іt presents​ tо sponsors, including what constitutes adequate diversity, potential data collection hurdles, and highlight upcoming FDA public workshops and guidances. If you are interested in more information all around Hogan Lovells Life Sciences and Health Care, follow us on LinkedIn and Twitter.
    Show more Show less
    20 mins
  • Talking the Cure - Discussing Artificial Intelligence in Medical Devices

    Talking the Cure - Discussing Artificial Intelligence in Medical Devices
    Jan 26 2023
    Arne Thiermann and Nicole Saurin talk about the current state and development of artificial intelligence in the medical device industry. How will AI medical devices be classified by the AIA Proposal? What is the relationship between the AIA Proposal and the MDR? What laws apply to the liability of medical AI products? Who is liable if the AI application makes a wrong decision? And a lot more questions about the regulations and potential liability issues around AI in the MedTech industry.
    Show more Show less
    35 mins
  • Talking the Cure - Discussing MedTech Color with Kwame Ulmer

    Talking the Cure - Discussing MedTech Color with Kwame Ulmer
    Nov 13 2022
    In this episode, Beth L. Roberts (Partner, Washington, D.C.) is talking to Kwame Ulmer (Founder and Executive Director) about MedTech Color, its mission, programs, and resources they provide. In addition, they’re discussing which hot topics in diversity and inclusion should medical devices, pharma, and other healthcare companies should be aware of, best practices regarding diversity recruitment and retention efforts as well as how to get involved with MedTech Color and take action in their day-to-day business to help advance the representation of persons of color in the medical device industry.
    Show more Show less
    21 mins
  • Talking the Cure - Exploring the industry with Ina Brock

    Talking the Cure - Exploring the industry with Ina Brock
    Sep 27 2022
    In this episode, Ina Brock invites us to her home and tells us that she actually wanted to become a journalist, but chance brought her to law. And the result of this decision is an impressive career, which we review together, Ina gives us insights into her daily work and how she sees the future of the Life Sciences & Healthcare Industry.
    Show more Show less
    49 mins
  • Talking the Cure - Discussing diversity in clinical trials

    Talking the Cure - Discussing diversity in clinical trials
    Jul 28 2022
    Robert F. Church, Sarah Thompson Schick, Stephanie Agu, and Akosua Tuffuor, J.D. discuss recent developments in FDA’s and industry’s approaches towards clinical trials and ensuring meaningful trial participation from members of historically underrepresented populations.
    Show more Show less
    36 mins